ASM Microbe Conference

Otto Schwake, PhD, discusses how he and his team sought to validate their hypothesis regarding climate and Legionella presence in car washer fluid.

Jason Gallagher, PharmD, BCPS, FCCP, FIDSA, explains how the role of antimicrobial susceptibility tests can be undermined by delays between approval of new antibiotics and the tests that will optimize their use.

Milena McLaughlin, PharmD, MSc, explains the key points that should be incorporated into institutional plans for dealing with antimicrobial shortages.

Elizabeth Phillips, MD, FRCPC, FRACP, explains different strategies for improving antibiotic allergy management.

Kenneth Mayer, MD, discusses the current challenges of improving pre-exposure prophylaxis delivery and adherence in the United States.

Meghan Jeffres, PharmD, explains what practitioners should keep in mind when prescribing beta-lactams.

Otto Schwake, PhD, explains how likely it is for someone to catch Legionnaire’s disease from windshield washer fluid.

Conan MacDougall, PharmD, discusses some interventions that have been shown to produce negative behavioral changes for antibiotic stewardship.

Kirk Hevener, PharmD, PhD, explains why narrow-spectrum antibiotics are more beneficial for treating C. difficile.

Milena McLaughlin, PharmD, MSc, explains strategies institutions can take to address antimicrobial shortages.

Jason Gallagher, PharmD, BCPS, FCCP, FIDSA, explains the importance of antimicrobial susceptibility testing for off-label indications.

Genovefa Papanicolaou, MD, discusses a new antiviral in development to prevent cytomegalovirus.

Otto Schwake, PhD, postulates how Legionella might get into automobile windshield washer fluid and if there is any way to prevent it.

Milena McLaughlin, PharmD, MSc, explains the different ways that antimicrobial shortages can impact patient care.

Khalid Eljaaly, PharmD, MS, CAPPS, BCPS, explains which studies are ideal to run through a meta-analysis.

Jeremy Burrows, DPhil, MA, explains how new antimalarials could change the game for countries where malaria is endemic.

Caetano P. Sabino, BSc, PhD Student, explains how photodynamic therapy works.

Elizabeth Phillips, MD, FRCPC, FRACP, explains the current preferred methods for drug skin testing and desensitization.

Kenneth Mayer, MD, shares some of the common concerns individuals have regarding the use of pre-exposure prophylaxis as protection against HIV.

Jason Pogue, PharmD, BCPS-ID, Clinical Pharmacist, Infectious Diseases, Sinai-Grace Hospital, explains why Pseudomonas aeruginosa is one of the World Health Organization’s critical priority pathogens for new research and development priorities.

Davey Legendre, PharmD, MBA, BCPS, sheds light on the prevalence of confirmed beta-lactam allergies in patients.

Benjamin Young, MD, PhD, shares how many catalysts for the HIV epidemic exist within cities.

Genovefa Papanicolaou, MD, explains in which patient population is CMV most harmful.

The impact of viruses on community-acquired pneumonia seems to be greater than initially realized and the use of procalcitonin may help distinguish infection type for appropriate treatment.

Contagion® sat down with Rodrigo Mendes, PhD, to discuss research exploring evolving resistance among antibiotics to treat skin infections.

Kirk Hevener, PharmD, PhD, explains the drawbacks of first-line drugs that are currently used to treat C. difficile infections.

The weekly Business Watch includes the latest industry news that practitioners working in infectious diseases need to know.

Genovefa Papanicolaou, MD, provides a brief overview of cytomegalovirus.

Conan MacDougall, PharmD, MAS, BCPS-AQ ID, sheds light on behavior change interventions that could positively affect antibiotic prescribing practices.

Thomas File, MD, MSc explains what pleuromutilin antibiotics are and how they work.